IP Library Granted Patent US 9,050,076
Granted Patent B2
US 9,050,076 · App. 13/073,660 · Granted Jun 9, 2015

Device and method for lung treatment

Inventors: Robert L. Barry (Kirkland, WA); Brian Cran (Seattle, WA); Dean Corcoran (Bothell, WA); Sheldon K. Lee (Seattle, WA)
Assignee: Uptake Medical Corp.
A61B18/04A61B2018/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,076
App. No.
13/073,660
Filed
Mar 28, 2011
Granted
Jun 9, 2015
Kind
B2
Art Unit
3769
USPC
128/898
Abstract

This invention relates to the treatment of a patient's lung, for example, a lung exhibiting chronic obstructive pulmonary disease (COPD) and in particular to methods and devices for affecting lung volume reduction, preferably for achieving acute or immediate lung volume reduction following treatment. The lung volume reduction is effected by delivering a condensable vapor at a temperature above body temperature to the desired regions of the patient's lung to damage tissue therein. Blood flow and air flow to the damaged tissue region is essentially terminated, rendering the target region non-functional. Alternative energy sources may be used to effect the thermal damage to the lung tissue.

Claims (18)

1. A method of treating a patient's lung comprising:

determining a predetermined volume of condensable vapor to deliver based on a diagnostic evaluation or a parameter of the patient;

after the determining step, delivering the predetermined volume of condensable vapor to a sub segmental bronchi of the patient's lung, and raising the temperature of tissue in the lung to render it non-functional.

2. The method of claim 1 further comprising monitoring pressure within the sub segmental bronchi and venting the sub segmental bronchi if a pressure limit is reached.

3. The method of claim 1 further comprising monitoring temperature within the sub segmental bronchi and lavaging the sub segmental bronchi if a temperature limit is reached.

4. The method of claim 1 wherein delivering the predetermined volume of the condensable vapor to the sub segmental bronchi of the patient's lung comprises inducing neointima hyperplasia in the lung.

5. The method of claim 1 wherein delivering the predetermined volume of the condensable vapor to the sub segmental bronchi of the patient's lung comprises inducing tissue injury and necrosis leading to fibrosis.

6. The method of claim 1 wherein a vacuum is generated within the sub segmental bronchi to facilitate collapse of tissue structures thereof.

7. The method of claim 6 wherein the tissue structures collapsed are at least one of the group consisting of an air sac of the patient's sub segmental bronchi, terminal bronchioles in the sub segmental bronchi and collateral passageways in the sub segmental bronchi.

8. A method of treating a patient's lung comprising:

determining a predetermined volume of condensable vapor to deliver based on a diagnostic evaluation or a parameter of the patient; and

after the determining step, delivering the predetermined volume of condensable vapor having a temperature of approximately 60 to 100 degrees C. to a targeted region of the patient's lung, and raising the temperature of tissue in the targeted region to render it non-functional.

9. The method of claim 8 further comprising monitoring pressure within the targeted region and venting the targeted region if a pressure limit is reached.

10. The method of claim 8 further comprising monitoring temperature within the targeted region and lavaging the targeting region if a temperature limit is reached.

11. The method of claim 8 wherein delivering the predetermined volume of the condensable vapor to the targeted region of the patient's lung comprises inducing neointima hyperplasia in the lung.

12. The method of claim 8 wherein delivering the predetermined volume of the condensable vapor to the targeted region of the patient's lung comprises inducing tissue injury and necrosis leading to fibrosis in the lung.

13. The method of claim 8 wherein a vacuum is generated within the targeted region to facilitate collapse of tissue structures thereof.

14. The method of claim 13 wherein the tissue structures collapsed are at least one of the group consisting of an air sac of the patient's targeted region, terminal bronchioles in the targeted region and collateral passageways in the targeted region.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2016
From: UPTAKE MEDICAL CORP.
To: UPTAKE MEDICAL TECHNOLOGY INC.
Reel/Frame 039388/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2011
From: LEE, SHELDON K.
To: UPTAKE MEDICAL CORP.
Reel/Frame 026486/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2011
From: BARRY, ROBERT L.; CRAN, BRIAN; CORCORAN, DEAN
To: UPTAKE MEDICAL CORP.
Reel/Frame 026259/0506 →
Continuity (4)
Continuation 11281212 · Nov 16, 2005
Provisional Application 60628451 · Nov 16, 2004
Provisional Application 60648036 · Jan 27, 2005
Related Publication 20110172654A1 · Jul 14, 2011